ripekg:integrity-assessment-hypothesis/RIPEA237F9DCBC31EFBBD-human-1-1 |
rdf:type |
rdfs:Resource |
ripekg:integrity-assessment-hypothesis/RIPEA237F9DCBC31EFBBD-human-1-1 |
rdf:type |
owl:Thing |
ripekg:integrity-assessment-hypothesis/RIPEA237F9DCBC31EFBBD-human-1-1 |
rdf:type |
ripe:IntegrityAssessmentHypothesisIntegrity assessment hypothesis |
ripekg:integrity-assessment-hypothesis/RIPEA237F9DCBC31EFBBD-human-1-1 |
rdf:type |
tido:Hypothesis |
ripekg:integrity-assessment-hypothesis/RIPEA237F9DCBC31EFBBD-human-1-1 |
rdf:type |
tido:PieceOfInformation |
ripekg:integrity-assessment-hypothesis/RIPEA237F9DCBC31EFBBD-human-1-1 |
prov:wasAttributedTo |
ripekg:human-reviewer/RV013 |
ripekg:integrity-assessment-hypothesis/RIPEA237F9DCBC31EFBBD-human-1-1 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEA237F9DCBC31EFBBD |
ripekg:integrity-assessment-hypothesis/RIPEA237F9DCBC31EFBBD-human-1-1 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA237F9DCBC31EFBBD |
ripekg:integrity-assessment-hypothesis/RIPEA237F9DCBC31EFBBD-human-1-1 |
ripe:rationale |
No journal webpage notice |
ripekg:integrity-assessment-hypothesis/RIPEA237F9DCBC31EFBBD-human-1-1 |
ripe:resultOutcome |
no |
ripekg:integrity-assessment-hypothesis/RIPEA237F9DCBC31EFBBD-human-1-1 |
tido:answers |
ripekg:integrity-assessment-question/retraction-status/1.0.01.1. Does the study have an associated retraction? |
ripekg:integrity-assessment-hypothesis/RIPEA237F9DCBC31EFBBD-human-1-1 |
tido:answers |
ripekg:integrity-assessment-question/retraction-status/1.0.0retraction status |
ripekg:publication-details/RIPEA237F9DCBC31EFBBDFour cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA237F9DCBC31EFBBD-human-1-1 |